RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in patients with untreated, EGFR-mutated, metastatic non-small cell lung cancer: Europe/United States subset analysis
Ponce Aix, S, Novello, S, Garon, EB, Nakagawa, K, Nadal, E, Moro-Sibilot, D, Alonso Garcia, M, Fabre, E, Frimodt-Moller, B, Zimmermann, AH, Visseren-Grul, CM, Reck, M
Published in Cancer treatment and research communications (2021)
Published in Cancer treatment and research communications (2021)
Get full text
Journal Article
1294P RELAY, erlotinib plus ramucirumab or placebo in untreated EGFR-mutated metastatic NSCLC: Outcomes by EGFR mutation type
Nakagawa, K., Nadal, E., Garon, E.B., Nishio, M., Seto, T., Yamamoto, N., Park, K., Shih, J-Y., Frimodt-Moller, B., Zimmermann, A.H., Visseren-Grul, C.M., Reck, M.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Patient-focused outcomes in RELAY, a phase III trial of ramucirumab plus erlotinib (RamErl) versus placebo plus ERL (PboErl) in untreated EGFR-mutated metastatic NSCLC (EGFR+ mNSCLC)
Yoh, K., Atagi, S., Reck, M., Garon, E.B., Aix, S. Ponce, Moro-Sibilot, D., Winfree, K.B., Frimodt-Moller, B., Zimmermann, A.H., Visseren-Grul, C.M., Nakagawa, K.
Published in Annals of oncology (01.11.2019)
Published in Annals of oncology (01.11.2019)
Get full text
Journal Article
P1.18-01 RELAY EU/US Subset: Ramucirumab Plus Erlotinib Improves Progression-Free Survival in First-Line EGFR Mutation-Positive NSCLC
Aix, S., Novello, S., Garon, E., Nakagawa, K., Nadal, E., Moro-Sibilot, D., Garcia, M. Alonso, Fabre, E., Frimodt-Moller, B., Zimmermann, A., Visseren-Grul, C., Reck, M.
Published in Journal of thoracic oncology (01.10.2019)
Published in Journal of thoracic oncology (01.10.2019)
Get full text
Journal Article
35P Final data from phase I/II LIBRETTO-001 trial of selpercatinib in RET fusion-positive non-small cell lung cancer
Gautschi, O., Drilon, A., Solomon, B., Tomasini, P., Loong, H.H.F., De Braud, F.G.M., Goto, K., Peterson, P., Barker, S., Liming, K., Frimodt-Moller, B., Park, K.
Published in ESMO open (01.03.2024)
Published in ESMO open (01.03.2024)
Get full text
Journal Article
Phase 1b expansion cohort study to evaluate the safety and efficacy of necitumumab and abemaciclib combination therapy in patients with stage IV non-small cell lung cancer (NSCLC)
Besse, B., Barlesi, F., Ceccarelli, M., Chao, G.Y., Frimodt-Moller, B., Gil, M., Vansteenkiste, J.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
135O A phase 1b study of necitumumab in combination with abemaciclib in patients with stage IV non-small cell lung cancer
Besse, B., Barlesi, F., Demedts, I., Fuentes Pradera, J., Renault, A., Robinet, G., Frimodt-Moller, B., Gil, M., Vansteenkiste, J.
Published in Journal of thoracic oncology (01.04.2018)
Published in Journal of thoracic oncology (01.04.2018)
Get full text
Journal Article
A phase 1b study of necitumumab in combination with abemaciclib in patients with stage IV non-small cell lung cancer: 135O
Besse, B, Barlesi, F, Demedts, I, Pradera, Fuentes J, Renault, A, Robinet, G, Frimodt-Moller, B, Gil, M, Vansteenkiste, J
Published in Journal of thoracic oncology (01.04.2018)
Published in Journal of thoracic oncology (01.04.2018)
Get full text
Journal Article
Quality-of-life (QoL) measures in advanced non-small cell lung cancer (NSCLC) patients and their association with treatment choices across 5 European countries: Preliminary data from the ACTION study
Pimental, F., Szczepura, A., Thomas, M., Frimodt-Moller, B., Belger, M., Watkins, J., Watt, M.
Published in Journal of clinical oncology (01.06.2005)
Published in Journal of clinical oncology (01.06.2005)
Get full text
Journal Article
Addressing the growing burden of trauma and injury in low- and middle-income countries
Fingerhut, Lois A, Harrison, James, Holder, Yvette, Frimodt-Møller, Birthe, Mackenzie, Susan, Mulder, Saakje, Scott, Ian
Published in American journal of public health (1971) (01.07.2005)
Published in American journal of public health (1971) (01.07.2005)
Get full text
Journal Article
P-458 Palliative chemotherapy of non-small cell lung cancer (NSCLC): Analysis of German baseline data from the ACTION observational study
Bischoff, H., Leschinger, M., Bhalla, S., Mueller, E., Frimodt-Moller, B., Bonnet, R., Steppert, O., Fischer, J., Boulori, H., Thomas, M.
Published in Lung cancer (Amsterdam, Netherlands) (01.07.2005)
Published in Lung cancer (Amsterdam, Netherlands) (01.07.2005)
Get full text
Journal Article
Accident registration by hospitals
Röck, Niels Dieter, Frimodt-Møller, Birthe, Larsen, Claus Falck
Published in Ugeskrift for læger (28.10.2002)
Get more information
Published in Ugeskrift for læger (28.10.2002)
Journal Article
Diagnosis and treatment in general practice. Referral courses over a period of 1 year
Heldrup, J, Frimodt-Møller, B, Gannik, D, Hollnagel, H, Pedersen, P A
Published in Ugeskrift for læger (23.01.1989)
Get more information
Published in Ugeskrift for læger (23.01.1989)
Journal Article
Diagnosis and treatment in general practice. I. The course of illness in primary health service
Heldrup, J, Frimodt-Møller, B, Gannik, D, Hollnagel, H, Pedersen, P A
Published in Ugeskrift for læger (16.01.1989)
Get more information
Published in Ugeskrift for læger (16.01.1989)
Journal Article
Diagnosis and treatment in general practice. 5. Attitudes of general practitioners--a review
Gannik, D, Frimodt-Møller, B, Heldrup, J, Hollnagel, H, Pedersen, P A
Published in Ugeskrift for læger (16.01.1989)
Get more information
Published in Ugeskrift for læger (16.01.1989)
Journal Article
Diagnosis and treatment in general practice. 4. General practitioners' knowledge of their patients
Pedersen, P A, Frimodt-Møller, B, Gannik, D, Heldrup, J, Hollnagel, H
Published in Ugeskrift for læger (16.01.1989)
Get more information
Published in Ugeskrift for læger (16.01.1989)
Journal Article